The Global South, historically bypassed by industrial revolutions, now has a unique opportunity to lead the emerging bioeconomy through biotechnology and deep tech innovation. While the Global North dominates AI with rapid development and regulatory challenges, the South faces risks from unregulated AI adoption without proportional market influence. Instead, by leveraging agricultural strengths and low-cost manufacturing, developing nations can cultivate high-value biotech industries, including biopharma, bioenergy, climate-resilient agriculture, and bioplastics. Policymakers must balance regulation and innovation to ensure equitable access and harness international cooperation. Addressing past missed opportunities in software and chip manufacturing, the Global South can reclaim leadership by focusing on biotech convergence amid geopolitical fragmentation and technological acceleration.
ICT,Health
Africa
14 October 2026
AI4AI
A World Economic Forum Initiative